Ascendis Pharma A (ASND) Other Non-Current Assets (2012 - 2021)

Ascendis Pharma A has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $2.0 million for Q3 2021.

• Other Non-Current Assets for Q3 2021 came in at $2.0 million, up 39.13% year-over-year; the trailing twelve-month figure through Sep 2021 was $2.0 million (up 39.13% YoY), and the FY2020 annual result was $1.6 million, up 1.24% from the prior year.
• Other Non-Current Assets came in at $2.0 million for Q3 2021 at Ascendis Pharma A, down from $2.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.0 million in Q2 2021 to a low of -$1.1 million in Q3 2018.
• The 5-year median for Other Non-Current Assets is $833362.4 (2017), against an average of $631360.7.
• Across the five-year window, Other Non-Current Assets slumped 94539.82% in 2018 and surged 61773.72% in 2020, its largest moves.
• Ascendis Pharma A's Other Non-Current Assets stood at $344987.7 in 2017, then surged by 283.13% to $1.3 million in 2018, then grew by 22.52% to $1.6 million in 2019, then climbed by 1.24% to $1.6 million in 2020, then increased by 23.22% to $2.0 million in 2021.
• The last three Other Non-Current Assets figures came in at $2.0 million (Q3 2021), $2.0 million (Q2 2021), and $1.6 million (Q4 2020), per Business Quant data.